Rilonacept FDA approval date

The FDA approved Rilonacept (Arcalyst® for Cryopyrin-Associated Periodic Syndromes (CAPS)) on 27 Feb 2008.

FDA approval date
27 Feb 2008

Drug identity checked against registry records

Also recorded as Arcalyst® for Cryopyrin-Associated Periodic Syndromes (CAPS); KPL-914

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2008-02-27DayRilonaceptFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125249", "applicant_as_listed_by_fda": "KINIKSA PHARMACEUTICALS (UK), LTD.", "brand_names": ["ARCALYST"], "active_ingredients": ["RILONACEPT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20080227", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026